Centogene is partnering with IQVIA to improve health outcomes for rare disease patients

March 2023

IQVIA and Centogene have formed a collaboration to improve health outcomes for rare disease patients by accelerating and de-risking clinical development and increasing access to genetic testing.

Through combined capabilities in real-world data and scalable partnering solutions, this collaboration will provide end-to-end support to enable better health outcomes, from precision medicine to data-driven drug discovery, development, and commercialization. Accelerating and streamlining clinical trials and genetic testing options is critical for bringing new innovative solutions to patients as efficiently as possible.

The link to the article can be found here.